# CORRESP — Verrica Pharmaceuticals Inc.  (VRCA)  (CIK 0001660334)

> <strong>Verrica Pharmaceuticals Inc.  (VRCA)  (CIK 0001660334) → SEC staff</strong> · filed 2025-12-19 · ticker VRCA · SIC 2834

## What is this

A CORRESP letter is the company's written reply to the SEC during a filing review. Responses include accounting position arguments, restatement assessments, and clarifying disclosures. Released to EDGAR alongside the SEC's UPLOAD letters.

## Key facts

- **Accession number:** 0001193125-25-326765
- **Form:** CORRESP
- **Filer:** Verrica Pharmaceuticals Inc.  (VRCA)  (CIK 0001660334)
- **CIK:** 0001660334
- **Ticker:** VRCA
- **Filed:** 2025-12-19
- **SIC industry:** 2834
- **HQ:** West Chester, PA

## Primary source

PDF letter: https://www.sec.gov/Archives/edgar/data/1660334/000119312525326765/filename1.htm

EDGAR review history for this filer: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1660334&type=UPLOAD&dateb=&owner=include&count=40

## Citation

> US Securities and Exchange Commission, EDGAR CORRESP comment letter, Verrica Pharmaceuticals Inc.  (VRCA)  (CIK 0001660334) (CIK 0001660334), filed 2025-12-19, accession 0001193125-25-326765. Retrieved via MORVS 2026-11-14 from https://api.morvs.ai/comment-letter/0001193125-25-326765.

---

*[SEC comment letters dataset](/datasets/sec-comment-letters) · CC0 1.0*